A. Karabelis

962 total citations
37 papers, 710 citations indexed

About

A. Karabelis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Karabelis has authored 37 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in A. Karabelis's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (7 papers) and Cancer Treatment and Pharmacology (6 papers). A. Karabelis is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (7 papers) and Cancer Treatment and Pharmacology (6 papers). A. Karabelis collaborates with scholars based in Greece, United States and Nigeria. A. Karabelis's co-authors include Christos Kosmas, Νicolas Tsavaris, John Syrios, H. Skopelitis, Petros Kopterides, Manolis S. Kallistratos, P. Kosmidis, Dimosthenis Skarlos, E. Samantas and C. Bacoyiannis and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

A. Karabelis

34 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Karabelis Greece 11 469 288 184 112 103 37 710
Marija Bojić Austria 10 364 0.8× 350 1.2× 353 1.9× 46 0.4× 283 2.7× 39 948
V.J. Harvey New Zealand 11 319 0.7× 176 0.6× 62 0.3× 88 0.8× 226 2.2× 24 678
Doğan Uncu Türkiye 15 348 0.7× 261 0.9× 47 0.3× 41 0.4× 80 0.8× 96 704
Matteo Brighenti Italy 12 628 1.3× 316 1.1× 51 0.3× 70 0.6× 182 1.8× 38 869
J.S. Abbatucci France 13 311 0.7× 418 1.5× 72 0.4× 60 0.5× 90 0.9× 18 799
M. Biakhov Russia 7 327 0.7× 221 0.8× 57 0.3× 105 0.9× 73 0.7× 19 899
Vishram B. Rege United States 14 484 1.0× 449 1.6× 36 0.2× 39 0.3× 98 1.0× 19 827
Graham J. Caine United Kingdom 10 213 0.5× 157 0.5× 296 1.6× 45 0.4× 195 1.9× 12 852
Marcella Occelli Italy 15 353 0.8× 176 0.6× 226 1.2× 13 0.1× 141 1.4× 29 691
E. Heidemann Germany 12 509 1.1× 155 0.5× 47 0.3× 220 2.0× 92 0.9× 42 793

Countries citing papers authored by A. Karabelis

Since Specialization
Citations

This map shows the geographic impact of A. Karabelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Karabelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Karabelis more than expected).

Fields of papers citing papers by A. Karabelis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Karabelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Karabelis. The network helps show where A. Karabelis may publish in the future.

Co-authorship network of co-authors of A. Karabelis

This figure shows the co-authorship network connecting the top 25 collaborators of A. Karabelis. A scholar is included among the top collaborators of A. Karabelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Karabelis. A. Karabelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kosmas, Christos, George Vorgias, Georgios Tsakonas, et al.. (2011). Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours. British Journal of Cancer. 105(7). 897–902. 2 indexed citations
2.
Kosmas, Christos, N. Mylonakis, Georgios Tsakonas, et al.. (2009). Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer. British Journal of Cancer. 101(7). 1059–1065. 24 indexed citations
3.
Kosmas, Christos, Νicolas Tsavaris, Nikolaos Malamos, et al.. (2007). Docetaxel–ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines. Investigational New Drugs. 25(5). 463–470.
4.
Kosmas, Christos, Manolis S. Kallistratos, Petros Kopterides, et al.. (2007). Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. Journal of Cancer Research and Clinical Oncology. 134(1). 75–82. 236 indexed citations
5.
Sipsas, Nikolaos V., Christos Kosmas, Panayiotis D. Ziakas, et al.. (2007). Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: Ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. Scandinavian Journal of Infectious Diseases. 39(9). 786–791. 5 indexed citations
6.
Kosmas, Christos, N. Tsavaris, N. Mylonakis, et al.. (2007). Docetaxel-Ifosfamide Combination in Patients with Advanced Breast Cancer Failing Prior Anthracycline- Based Regimens: Results of a Phase I-II Study. Journal of Chemotherapy. 19(3). 322–331. 3 indexed citations
7.
Pectasides, Dimitrios, Petroula Arapantoni-Dadioti, Christos Valavanis, et al.. (2006). HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.. PubMed. 26(1B). 647–53. 58 indexed citations
8.
Kosmas, Christos, Νicolas Tsavaris, Konstantinos Syrigos, et al.. (2006). A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens. Cancer Chemotherapy and Pharmacology. 59(1). 51–59. 20 indexed citations
9.
Nikolaou, Maria, et al.. (2006). Intramedullary Spinal Cord Metastases from Atypical Small Cell Lung Cancer: A Case Report and Literature Review. Cancer Investigation. 24(1). 46–49. 7 indexed citations
10.
11.
Kosmas, Christos, Νicolas Tsavaris, Thomas Makatsoris, et al.. (2005). A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer. Oncology. 69(4). 333–341. 2 indexed citations
12.
Christodoulou, C., Dimitrios Bafaloukos, P. Kosmidis, et al.. (2001). Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Annals of Oncology. 12(2). 249–254. 143 indexed citations
13.
Nicolaides, C., George Fountzilas, Nicholas Zoumbos, et al.. (1998). Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index. Oncology. 55(5). 405–415. 31 indexed citations
14.
Tsavaris, Νicolas, et al.. (1994). Comparison of Ondansentron (GR 38032F) Versus Ondansentron plus Alprazolam as Antiemetic Prophylaxis During Cisplatin-Containing Chemotherapy. American Journal of Clinical Oncology. 17(6). 516–521. 6 indexed citations
15.
Mylonakis, N., et al.. (1993). Treatment of Renal Cell Carcinoma with Escalating Doses of Alpha-lnterferon. Chemotherapy. 39(5). 361–366. 7 indexed citations
16.
Bafaloukos, Dimitrios, et al.. (1993). First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer. European Journal of Cancer. 29(6). 851–853. 4 indexed citations
17.
Tsavaris, Νicolas, et al.. (1992). A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer. Annals of Oncology. 3(2). 127–130. 14 indexed citations
18.
Kosmidis, P., Constantin N. Baxevanis, Nick B. Tsavaris, et al.. (1992). The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b.. Journal of Clinical Oncology. 10(7). 1153–1157. 15 indexed citations
19.
Tsavaris, Νicolas, et al.. (1990). Association of Neutrophil Alkaline Phosphatase Activity and Glycosylated Haemoglobin in Diabetes mellitus. Acta Haematologica. 83(1). 22–25. 4 indexed citations
20.
Tsavaris, Νicolas, et al.. (1990). Concomitant Administration of 4-Hydroxypyrazolopyrimidine (Allopurinol) and High-Dose Continuous Infusion 5-Fluorouracil. Oncology. 47(1). 70–74. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marija Bojić Breakdown of academic impact, for papers by V.J. Harvey Breakdown of academic impact, for papers by Doğan Uncu Breakdown of academic impact, for papers by Matteo Brighenti Breakdown of academic impact, for papers by J.S. Abbatucci Breakdown of academic impact, for papers by M. Biakhov Breakdown of academic impact, for papers by Vishram B. Rege Breakdown of academic impact, for papers by Graham J. Caine Breakdown of academic impact, for papers by Marcella Occelli Breakdown of academic impact, for papers by E. Heidemann
Rankless by CCL
2026